Since the activation of OX induces insomnia, and the risk of T2DM was increased with disturbed sleep and increased OX, OX antagonists improved glucose tolerance when administered to mice models of T2DM during their resting phase [173]. The gene discussed is HCRT; the disease is type 2 diabetes mellitus.